| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |